stall on tirzepatide Most stalls aren’t the GLP-1 failing. They’re a dose schedule built for a study, not for you, plus four metabolic roadblocks nobody checked. , Save this before your next dose increase‼️, ———, #reels Why Mounjaro Stops Working: Breakthrough

The main adverse effects described in clinical trials employing tirzepatide were gastrointestinal, such as nausea, diarrhea, decreased appetite, delayed gastric emptying, vomiting, acid reflux, and constipation (57)

Kumar, S., Das, G., Shin, S., & Patra, J

These newer obesity therapies as well as others in development that also have promising cardiovascular risk reduction benefits are among the most important developments in obesity and cardiovascular medicine in the past decade. The SURMOUNT-MMO trial testing the effects of tirzepatide on actual cardiovascular outcomes in persons with overweight and obesity both with and without prior cardiovascular disease is currently in progress and expected to read out in 2027

Human fibroblasts cultured in serum-free conditions regained full viability and proliferative capacity at GHK concentrations as low as 10 M (one nanomolar) suggesting extraordinary potency for fibroblast recovery applications

Would we all of a sudden discover that they have these magical weight loss powers beyond what we already know

Herein lies the importance of a balanced diet